Joseph Passarelli

Joseph Passarelli retired in 2024 after a career at Roche Diagnostics that spanned almost 40 years. In his latest role and for several years, Joe represented Roche as a scientific liaison to professional societies and standard- and guideline-setting organizations worldwide. He has worked both domestically and internationally in research and development and has experience in discovery, research, development, laboratory management, technology transfer, regulatory submissions, and market commercialization. His scientific background included developing immunoassays that used multiple technologies for homogenous laboratory-based testing platforms. He is recognized in the fields of drugs of abuse testing and therapeutic drug monitoring. Before this latest role, Mr. Passarelli was head of Roche Diagnostics Research and Development for these scientific disciplines.

Mr. Passarelli has been active with CLSI for several years, having participated on the document development committees for the EP05, EP06, EP07, EP09, and EP17 revisions. In addition, he was a member of the Consensus Committee on Clinical Chemistry and Toxicology and the Consensus Council. In addition to his collaboration with CLSI, Mr. Passarelli served in various leadership roles with the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) and the Association for Diagnostics and Laboratory Medicine (ADLM). He is passionate about educating and promoting the value of standardization and harmonization using recognized standards and guidelines and collaborates extensively with professional organizations worldwide.